Research Brief
Storing Foxo4 Dri: Best Practices
Pó Liofilizado
Store at -20°C or lower para manter stability. The liofilizado form is highly estavel due to D-aminoacido composition. Keep sealed, away from moisture and light.
Solução Reconstituída
Dissolve in PBS (Phosphate Buffered Saline) or sterile water. Prepare stock solutions at 2 mM or 5 mg/mL. Keep reconstituted solutions on ice and use promptly. Aliquot stock solutions para prevenir freeze-thaw cycles que may degrade o peptideo apesar de its protease resistance.
Manuseio
White liofilizado powder, typically supplied como um(a) TFA (trifluoroacetic acid) salt. Purity: ≥95–98% by HPLC. Identity: Mass Spectrometry (~5358.05 Da). The D-Retro-Inverso modification provides exceptional resistance to proteolytic degradacao, with intracellular detection até 72 hours post-administration.
Referencias
- Baar MP, et al. Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging. Cell, 169(1), 132-147.e16, 2017.
- Bourgeois B, et al. The disordered p53 transativacao domain e o(a) target of FOXO4 e o(a) senolytic compound FOXO4-DRI. Nature Communications, 16(1), 5672, 2025.
- Bourgeois B, Madl T. Regulation of cellular senescencia via o(a) FOXO4-p53 axis. FEBS Letters, 592(12), 2083-2097, 2018.
- Zhang C, et al. FOXO4-DRI alleviates age-related testosterone secretion insufficiency by targeting senescent Leydig cells in camundongos idosos. Aging, 12(2), 1272-1284, 2020.
- Hu Z, et al. FOXO4-DRI regula celula endotelial senescencia via o(a) P53 via de sinalizacao. Frontiers in Bioengineering and Biotechnology, 13, 1729166, 2026.
- Huang Y, et al. Senolytic Peptide FOXO4-DRI Selectively Removes Senescent Cells From in vitro Expanded Human Chondrocytes. Frontiers in Bioengineering and Biotechnology, 9, 677576, 2021.
- Li Y, et al. FOXO4-DRI melhora spermatogenesis in camundongos idosos through reducing senescencia-associated secretory phenotype secretion from Leydig cells. Experimental Gerontology, 195, 112522, 2024.
- Han X, et al. FOXO4 peptide direciona myofibroblaspara melhorars bleomycin-induziu pulmonar fibrose in mice through ECM-receptor interaction pathway. Journal of Cellular and Molecular Medicine, 26(11), 3269-3280, 2022.
- Liu Y, et al. FOXO4-D-Retro-Inverso direciona matriz extracelular production in fibroblastos and melhora bleomycin-induziu pulmonar fibrose in mice. Naunyn-Schmiedeberg's Archives of Pharmacology, 396(10), 2393-2403, 2023.
- Putavet DA, et al. Abstract IA002: Targeting senescencia heterogeneity against cancer therapy-resistance and metastases. Cancer Research, 81(5_Supplement), IA002, 2021.
- Meng J, et al. Targeting senescencia-like fibroblastos radiosensitizes non-small cell lung cancer and reduz radiation-induziu pulmonar fibrose. JCI Insight, 6(23), e146334, 2021.
- Krimpenfort P, Berns A. Rejuvenation by Therapeutic Elimination of Senescent Cells. Cell, 169(1), 3-5, 2017.
- Mandal R, et al. FOXO4 interage com p53 TAD and CRD and inibe its binding to DNA. Protein Science, 31(5), e4287, 2022.
- Kong YX, et al. FOXO4-DRI induz keloid senescent fibroblasto apoptose by promoting nuclear exclusion of upregulou p53-serine 15 fosforilacao. Communications Biology, 8(1), 299, 2025.
- van Willigenburg H, de Keizer PLJ, de Bruin RWF. Cellular senescencia como um(a) therapeutic target para melhorar renal transplantation outcome. Pharmacological Research, 130, 322-330, 2018.
- Putavet D, et al. Abstract P1-19-02: Repurposing the FOXO4 senolytic against triple-negative breast cancer. Cancer Research, 82(4_Supplement), P1-19-02, 2022.
- Nwankwo N, Okafor I. Bioinformatics procedure for investigating senolytic (anti-envelhecimento) agents: A digital signal processing technique. Aging Medicine, 6(4), 338-346, 2024.
- Timucin E, et al. Novel Senolytic Peptides. United States Patent Application, US20200255489A1, 2020.
Perguntas de Pesquisa Relacionadas
APENAS PARA USO EM PESQUISA
Este conteudo e fornecido apenas para fins educacionais e informativos. Os produtos sao fornecidos apenas para estudos in vitro e nao sao medicamentos, drogas ou suplementos. Nao aprovado pela FDA para prevenir, tratar ou curar qualquer condicao.